Olaratumab
| CAS No. | 1024603-93-7 | Cat. No. | BCP30495 |
| Name | Olaratumab | ||
| Synonyms | Lartruvo;IMC-3G3;LY-3012207;IMC3G3;LY3012207;IMC 3G3;LY 3012207; | ||
| Formula | C6554H10076N1736O2048S40 | M. Wt | 147.2 kg/mol |
| Description | Olaratumab is a monoclonal antibody for the treatment of solid tumors. Olaratumab inhibits growth of tumour cells by blocking subunit alpha of the platelet-derived growth factor receptor, a type of tyrosine kinase. | ||
| Pathways | Angiogenesis/Protein Tyrosine Kinase | ||
| Targets | PDGFR | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.